NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.   The most up-to-date information for company-wide success. Buyers […]

NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide […]

Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet […]

Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular […]

The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are […]

Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. […]

Diagnostic testing plays a crucial role in animal healthcare, offering veterinarians a diverse range of tests for disease identification and monitoring. The efficacy of diagnostic testing relies on swift, reliable, and accurate methods, facilitating informed diagnoses. Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. […]

Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated […]

Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th […]

While the concepts of gene therapy and cell therapy have been investigated for decades, there were major challenges in the early years.  Through incremental progress, and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing (NGS), cell and gene therapy has emerged into a highly active area.  There are now many approved […]